Table 2 Patient characteristics and tumor progression
From: KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)
No. | Stage | Therapy | Progression |
|---|---|---|---|
1 | pT4, N1b (18/21), MX, R0 | Total thyroidectomy, left central neck dissection, resection of the left recurrent laryngeal nerve and the left internal jugular vein, chemotherapy, radiation (50 Gy) After recurrence: Tumorectomy, bilateral neck dissection, transsternal lymphadenectomy | Local recurrence after 2 months |
2 | pT3, N0 (0/5), MX, R0 | Thyroidectomy, cervico-central lymphadenectomy | No recurrence (time of observation: 36 months) |
3 | pT3, N0, MX | Subtotal thyroidectomy, local telecobalttherapy of the neck (60 Gy) | No recurrence (time of observation: 19 months) |
4 | pT2, N0 (0/7), MX | Hemithyroidectomy right, then restthyroidectomy, microdissection of the cervicocentral compartment, radiation of the thyroidbed (59,4 Gy) | No recurrence (time of observation: 15 months) |
5 | pT3, N1 (1/19), MX | En bloc resection with the right lobe, neurolysis N.laryngeus recurrens right, neck dissection right, supraclavicular cervical lateral dissection, radiation (50 Gy) | No recurrence (time of observation: 17 months) |
6 | pT4a, N1 (1/5), M0, R0 | Total thyroidectomy, neck dissection, radiation of the neck region (50 Gy) | No recurrence (time of observation: 22 months) |